← Back to headlines
Lupin Achieves Top Global Pharma Ranking in S&P ESG Assessment 2025
Indian pharmaceutical company Lupin has been recognized as the number one globally in the pharma sector and across all sectors in India in the S&P ESG Assessment for 2025.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Israel Innovation Authority Launches New Deep Tech Funding Program
just now
Philippine Lottery Draws on June 30 Yield No Jackpot Winners
just now
Nigerian Railway Corporation Suspends Kajola-Apapa Train Service for Maintenance
21m ago